{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-009132","form_type":"8-K","ticker":"ALLR","cik":"0001860657","company_name":"Allarity Therapeutics, Inc.","filed_at":"2025-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.357017+00:00","generated_at":"2026-05-24T06:05:30.309123+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Allarity Therapeutics engages ShareIntel to investigate potential illegal naked short selling","bullets":["Engaged Shareholder Intelligence Services (ShareIntel) to probe potential illegal naked short selling and trading irregularities.","Will use ShareIntel's DRIL-Down™ platform to analyze trading data from broker-dealers and clearing firms.","CEO Thomas Jensen cites investor inquiries and notable stock volatility as drivers for the investigation.","If violations of SEC Regulation SHO are found, Allarity will consider legal recourse against responsible parties.","Investigation aims to protect shareholder value as the company advances clinical development of stenoparib."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-009132","json":"https://secwatch.observer/filing/0001437749-25-009132.json","markdown":"https://secwatch.observer/filing/0001437749-25-009132.md","text":"https://secwatch.observer/filing/0001437749-25-009132.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860657/000143774925009132/0001437749-25-009132-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860657/000143774925009132/allr20250324_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T06:05:30.309123+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}